The effect of sarcopenic visceral obesity on the risk of nonalcoholic fatty liver disease (NAFLD) is uncertain. We investigated (a) whether the skeletal muscle mass to visceral fat area ratio (SV ratio), as a measure of sarcopenic visceral obesity, is a risk factor for NAFLD; and (b) whether the SV ratio adds to conventional adiposity measures to improve prediction of incident NAFLD. Adults without NAFLD (n = 151,017) were followed up for a median of 3.7 years. Hepatic steatosis was measured using ultrasonography, and liver fibrosis scores were estimated using the Fibrosis-4 index (FIB-4) and the NAFLD Fibrosis Score (NFS). Cox proportional hazards models were used to determine sex-specific adjusted hazard ratios (aHRs) (95% confidence inte...
Background: The present study aimed to evaluate the correlation between hepatic steatosis (HS), dete...
Low skeletal muscle mass (LSMM) has emerged as a potential risk factor for non-alcoholic fatty liver...
Introduction: Non-alcoholic fatty liver disease (NAFLD) is the most frequent cause of liver disease,...
Nonalcoholic fatty liver disease (NAFLD) is the most prevalent liver disease worldwide. Obesity is a...
Sarcopenic obesity is regarded as a risk factor for the progression and development of non-alcoholic...
Takashi Shida,1 Natsumi Oshida,2 Sechang Oh,3 Kosuke Okada,1 Junichi Shoda41Tsukuba Preventive Medic...
A relationship between nonalcoholic fatty liver disease (NAFLD) and sarcopenia has been suggested. T...
Background: Nowadays, non-alcoholic fatty liver disease (NAFLD) is considered as the hepatic manifes...
BACKGROUND AND AIM: Although a combination of central obesity and decreased skeletal muscle mass has...
<p><strong>Objectives</strong>: Sarcopenia is a known risk factor for non-alcoholi...
Recent studies have investigated the relationship between sarcopenia and non-alcoholic fatty liver d...
Accumulating evidence supports a connection between sarcopenic obesity (SO) and NAFLD. The extent to...
Background & Aims Increased visceral adiposity is considered the hallmark of the metabolic syndrome,...
Although sarcopenia is known to be a risk factor for non-alcoholic fatty liver disease (NAFLD), whet...
Adipose tissue and skeletal muscle is associated with non-alcoholic fatty liver disease (NAFLD). Thi...
Background: The present study aimed to evaluate the correlation between hepatic steatosis (HS), dete...
Low skeletal muscle mass (LSMM) has emerged as a potential risk factor for non-alcoholic fatty liver...
Introduction: Non-alcoholic fatty liver disease (NAFLD) is the most frequent cause of liver disease,...
Nonalcoholic fatty liver disease (NAFLD) is the most prevalent liver disease worldwide. Obesity is a...
Sarcopenic obesity is regarded as a risk factor for the progression and development of non-alcoholic...
Takashi Shida,1 Natsumi Oshida,2 Sechang Oh,3 Kosuke Okada,1 Junichi Shoda41Tsukuba Preventive Medic...
A relationship between nonalcoholic fatty liver disease (NAFLD) and sarcopenia has been suggested. T...
Background: Nowadays, non-alcoholic fatty liver disease (NAFLD) is considered as the hepatic manifes...
BACKGROUND AND AIM: Although a combination of central obesity and decreased skeletal muscle mass has...
<p><strong>Objectives</strong>: Sarcopenia is a known risk factor for non-alcoholi...
Recent studies have investigated the relationship between sarcopenia and non-alcoholic fatty liver d...
Accumulating evidence supports a connection between sarcopenic obesity (SO) and NAFLD. The extent to...
Background & Aims Increased visceral adiposity is considered the hallmark of the metabolic syndrome,...
Although sarcopenia is known to be a risk factor for non-alcoholic fatty liver disease (NAFLD), whet...
Adipose tissue and skeletal muscle is associated with non-alcoholic fatty liver disease (NAFLD). Thi...
Background: The present study aimed to evaluate the correlation between hepatic steatosis (HS), dete...
Low skeletal muscle mass (LSMM) has emerged as a potential risk factor for non-alcoholic fatty liver...
Introduction: Non-alcoholic fatty liver disease (NAFLD) is the most frequent cause of liver disease,...